Autologous Transplantation of P63+Lung Progenitor Cells for Chronic Obstructive Pulmonary Disease Therapy: An Open-label, Controlled, First-in-Human Trial

被引：0
|
作者：
Zhang, T. [1 ]
Wang, Y. [2 ]
Zhou, Y. [1 ]
Zhao, Y. [2 ]
Zuo, W. [2 ]
机构：
[1] Regend Therapeut, Shanghai, Peoples R China
[2] Tongji Univ, Stem Cell Ctr, Shanghai, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1221
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial
    Lindsay, James O.
    Hind, Daniel
    Swaby, Lizzie
    Berntsson, Hannah
    Bradburn, Mike
    Bannur, C. Uday
    Byrne, Jennifer
    Clarke, Christopher
    Desoysa, Lauren
    Dickins, Ben
    Din, Shahida
    Emsley, Richard
    Foulds, Gemma A.
    Gribben, John
    Hawkey, Christopher
    Irving, Peter M.
    Kazmi, Majid
    Lee, Ellen
    Loban, Amanda
    Lobo, Alan
    Mahida, Yashwant
    Moran, Gordon W.
    Papaioannou, Diana
    Parkes, Miles
    Peniket, Andrew
    Pockley, A. Graham
    Satsangi, Jack
    Subramanian, Sreedhar
    Travis, Simon
    Turton, Emily
    Uttenthal, Ben
    Rutella, Sergio
    Snowden, John A.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (04): : 333 - 345
  • [42] Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up
    Wu, Zhixian
    Xu, Xiumin
    Cai, Jinquan
    Chen, Jin
    Huang, Lianghu
    Wu, Weizhen
    Pugliese, Alberto
    Li, Shasha
    Ricordi, Camillo
    Tan, Jianming
    CYTOTHERAPY, 2022, 24 (04) : 421 - 427
  • [43] Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
    Thatcher, Nick
    Hirsch, Fred R.
    Luft, Alexander V.
    Szczesna, Aleksandro
    Ciuleanu, Tudor E.
    Dediu, Mircea
    Ramlau, Rodryg
    Galiulin, Rinat K.
    Balint, Beatrix
    Losonczy, Gyoergy
    Kazarnowicz, Andrzej
    Park, Keunchil
    Schumann, Christian
    Reck, Martin
    Depenbrock, Henrik
    Nanda, Shivani
    Letunic, Anamarija Kruljac
    Kurek, Raffacl
    Paz-Ares, Luis
    Socinskf, Mark A.
    LANCET ONCOLOGY, 2015, 16 (07): : 763 - 774
  • [44] Intracoronary Injection of Autologous CD34+Cells Improves One-Year Left Ventricular Systolic Function in Patients with Diffuse Coronary Artery Disease and Preserved Cardiac Performance-A Randomized, Open-Label, Controlled Phase II Clinical Trial
    Sung, Pei-Hsun
    Li, Yi-Chen
    Lee, Mel S.
    Hsiao, Hao-Yi
    Ma, Ming-Chun
    Pei, Sung-Nan
    Chiang, Hsin-Ju
    Lee, Fan-Yen
    Yip, Hon-Kan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [45] Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Rescue2-monitor): an open-label, prospective randomized, controlled, superiority clinical trial comparing hospital- versus home-based acute non-invasive ventilation for patients with hypercapnic chronic obstructive pulmonary disease
    Trials, 21 (1)
  • [46] Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Rescue2-monitor): an open-label, prospective randomized, controlled, superiority clinical trial comparing hospital- versus home-based acute non-invasive ventilation for patients with hypercapnic chronic obstructive pulmonary disease
    Gonzalez-Bermejo, J.
    Gonzalez-Bermejo, J.
    Hajage, D.
    Durand-Zaleski, I.
    Arnal, J. M.
    Cuvelier, A.
    Grassion, L.
    Jaffre, S.
    Lamia, B.
    Pontier, S.
    Prigent, A.
    Rabec, C.
    Raherison-Semjen, C.
    Saint Raymond, C.
    Soler, J.
    Trzepizur, W.
    Winck, J. C.
    Aguiar, M.
    Chaves, H.
    Conde, B.
    Guimaraes, M. J.
    Lopes, P.
    Mineiro, A.
    Moreira, S.
    Pamplona, P.
    Rodrigues, C. M.
    Sousa, S.
    Anton, A.
    Cordoba-Izquierdo, A.
    Embid, C.
    Esteban Gonzalez, C.
    Ezzine, F.
    Garcia, P.
    Gonzalez, M.
    Guerassimova, I.
    Lopez, D.
    Lujan, M.
    Marti Beltran, S.
    Martinez, J. M.
    Masa, F.
    Pascual, N.
    Penacoba, N.
    Resano, P.
    Rey, L.
    Rodriguez Jerez, F.
    Roncero, A.
    Sancho Chinesta, Je.
    Sayas Catalan, Ja
    TRIALS, 2020, 21 (01)
  • [47] A first-in-human, phase 1, open-label trial of FX201, an intra-articular, helper-dependent adenoviral gene therapy for osteoarthritis - preliminary evaluation of clinical activity in 8 patients from the mid-dose cohort of a single ascending dose study design
    Kivitz, A.
    Senter, B.
    Golod, D.
    Parenti, D.
    Cinar, A.
    Hong, W.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A73 - A73
  • [48] Correction to: Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Rescue2-monitor): an open-label, prospective randomized, controlled, superiority clinical trial comparing hospital- versus home-based acute non-invasive ventilation for patients with hypercapnic chronic obstructive pulmonary disease
    Trials, 21
  • [49] Effects of Low-Dose Glucocorticoid Prophylaxis on Chronic Graft-versus-Host Disease and Graft-versus-Host Disease-Free, Relapse-Free Survival after Haploidentical Transplantation: Long-Term Follow-Up of a Controlled, Randomized Open-Label Trial
    Chang, Ying-Jun
    Xu, Lan-Ping
    Wang, Yu
    Zhang, Xiao-Hui
    Chen, Huan
    Chen, Yu-Hong
    Wang, Feng-Rong
    Han, Wei
    Sun, Yu-Qian
    Yan, Chen-Han
    Tang, Fei-Fei
    Mo, Xiao-Dong
    Liu, Kai-Yan
    Huang, Xiao-Jun
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03) : 529 - 537
  • [50] A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory multiple myeloma (CAMMOUFLAGE trial).
    Berdeja, Jesus G.
    Martin, Thomas G.
    Rossi, Adriana
    Essell, James H.
    Siegel, David Samuel DiCapua
    Mailankody, Sham
    Saini, Neeraj
    Holmes, Houston
    Dhakal, Binod
    Gasparetto, Cristina J.
    Parekh, Samir S.
    Portella, Socorro
    Ledergor, Guy
    Hammad, Ashley
    Davi, Franco
    Skoble, Justin
    Garner, Elizabeth
    Kanner, Steven Brian
    Rizvi, Syed
    Jagannath, Sundar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345